Jennifer Keiser: Clinical Trials

17 trials sponsored by Jennifer Keiser, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 2 not yet recruiting, 1 recruiting. 10 Phase 2, 8 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 210Completed 8, Not yet recruiting 1, Recruiting 1
Phase 38Completed 7, Not yet recruiting 1
Phase 41Completed 1

Follow Jennifer Keiser: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita
Emodepside, Albendazole 400 mg - Trichuris Infection
Phase 2Not yet recruitingJennifer Keiser1002026-11-152026-08-14
Follow-up Assessment of Change in Soil-transmitted Helminths Infection Intensity in Uganda
Albendazole 400mg, Ivermectin 3 mg - Ascariasis
Phase 3Not yet recruitingJennifer Keiser4502026-10-012026-10-14
Efficacy and Safety of Ascending Doses of Arpraziquantel in Children Infected With Opisthorchis Viverrini
Apraziquantel - Opisthorchis Viverrini
Phase 2RecruitingJennifer Keiser1252026-07-222026-08-04
Efficacy and Safety of Oxantel Pamoate in Children Infected With Trichuris Trichiura
Oxantel Pamoate, Mebendazole - Trichuris Trichiura; Infection, Hookworm Infection
Phase 2CompletedJennifer Keiser1632025-04-162025-06-08
Co-administration of IVM and ALB in School-based Deworming in Uganda
Albendazole 400mg, Ivermectin 3 MG - Helminthiasis, Intestinal Worms
CompletedJennifer Keiser87672024-07-012024-12-20
Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC
Ivermectin 1.5 mg ODT, Ivermectin 3 mg Oral Tablet, Albendazole 400 mg Oral Tablet - Trichuriasis, Ascariasis
Phase 2CompletedJennifer Keiser2602024-06-052025-09-22
Efficacy and Safety of Moxidectin-Albendazole Co-administration in SAC
Moxidectin 2 mg Oral Tablet, Albendazole 400 mg Oral Tablet, Placebo Moxidectin - Trichuriasis, Ascariasis
Phase 3CompletedJennifer Keiser2242024-05-142025-09-19
Efficacy of Ivermectin-albendazole vs Albendazole Alone in School-aged Children Infected With Trichuris Trichiura
IVM (200 µg/kg) + ALB (400 mg), ALB (400mg) - Trichuriasis
Phase 3CompletedJennifer Keiser1612023-10-092024-04-10
Efficacy and Safety of Emodepside in Adolescents and Adults Infected With Hookworm
Emodepside, Albendazole 400mg - Hookworm Infections
Phase 2CompletedJennifer Keiser3202022-09-162023-06-15
Efficacy and Safety of Moxidectin Versus Ivermectin Against Strongyloides Stercoralis
Moxidectin 2 mg, Ivermectin 3 mg, Placebo - Strongyloides Stercoralis Infection
Phase 3CompletedJennifer Keiser3322022-02-052024-01-25
Efficacy and Safety of Emodepside in Adults Infected With Trichuris Trichiura and Hookworm
Emodepside - Trichuris Trichiura; Infection, Hookworm Infections
Phase 2CompletedJennifer Keiser4422021-08-022022-05-27
Efficacy and Safety of MOX/ALB Co-administration
Moxidectin 2 mg Oral Tablet, Albendazole 400 mg Oral Tablet, Ivermectin 3 mg Oral Tablet - Trichuriasis, Ascariasis
Phase 3CompletedJennifer Keiser2552021-06-152024-01-24
Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration
moxidectin (8 mg) / albendazole (400 mg), ivermectin (200 µg/kg) / albendazole (400 mg), ALBENDAZOLE 400 Mg ORAL TABLET [ZENTEL] - Trichuriasis, Ascariasis
Phase 2 / Phase 3CompletedJennifer Keiser5362021-03-012024-12-05
Efficacy, Safety, and PK of Ascending Dosages of Moxidectin Versus Ivermectin Against Strongyloides Stercoralis
Moxidectin, Ivermectin, Placebo oral tablet - Strongyloides Stercoralis Infection
Phase 2 / Phase 3CompletedJennifer Keiser6172019-11-272024-12-09
Albendazole Dose Finding and Pharmacokinetics in Children and Adults
Albendazole, Placebo - Trichuriasis, Hookworm Infections
Phase 2CompletedJennifer Keiser7002018-10-232023-06-12
Efficacy and Safety of IVM/ALB Co-administration
Albendazole, Albendazole and Ivermectin - Trichuriasis
Phase 2 / Phase 3CompletedJennifer Keiser16732018-09-092024-03-20
Efficacy and Safety of a Multi-dose Regimen of Mebendazole Against Hookworm in Children
Treatment with one of the two regimens of mebendazole - Hookworm
Phase 4CompletedJennifer Keiser1862017-07-252019-06-17

Conditions studied

Trichuriasis (10)  ·  Hookworm Infections (8)  ·  Ancylostomiasis (7)  ·  Ascariasis (5)  ·  Helminthiasis (2)  ·  Intestinal Diseases, Parasitic (1)

Interventions

Albendazole (11)  ·  Ivermectin (9)  ·  moxidectin (5)  ·  Tablets (4)  ·  emodepside (3)  ·  Albumins (1)  ·  Intravital Microscopy (1)  ·  Mebendazole (1)  ·  Therapeutics (1)  ·  oxantel pamoate (1)

Countries

Tanzania (8)  ·  Côte d’Ivoire (3)  ·  Laos (3)  ·  Uganda (3)  ·  Cambodia (1)

Results publications

PMID 37949090, PMID 30885157, PMID 31193620, PMID 32405623, PMID 32668456, PMID 33798487, PMID 34191812, PMID 34296417, PMID 34632308, PMID 34856181, PMID 35217670, PMID 36354034, PMID 37195942, PMID 37195949, PMID 37357904, PMID 38517907, PMID 39153818, PMID 39591454, PMID 40675166, PMID 40975108, PMID 42486129